Speaker BIO:

Doron M. Behar (Shaare Zedek Medical Center, Jerusalem, Israel) holds an MD and PhD degrees from the Technion - Israel Institute of Technology. At his capacity as an MD he graduated three specialization programs in Internal Medicine, Critical Care Medicine and Medical Genetics. His PhD thesis was in the field of Population Genetics. Dr. Behar has multiyear background experience in the development of genetic testing for the public using a direct internet based customer approach at his capacity as the chief medical officer of Gene by Gene Ltd. His primary interest is in developing robust, low-priced genetic testing to the general public that will allow the hope of responsible personalized genetic medicine to any individual worldwide.

Speaker BIO:

EDUCATION AND CERTIFICATION
AMERICAN BOARD OF GENETIC COUNSELING
• Diplomate since 2007.
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON – Houston, TX.
• M.Sc. Genetic Counseling.
• Thesis: Hispanics’ attitudes, knowledge and beliefs regarding familial colorectal cancer (CRC) and CRC screening.
STANFORD UNIVERSITY – Stanford, CA.
• B.A. Human Biology, concentration on Genetics and Genetic Testing.

PROFESSIONAL EXPERIENCE
DIRECTOR, GENETIC COUNSELORS 2009 - present
Counsyl - South San Francisco, CA.
• Counsyl is a health technology company that delivers counseling and testing for inherited disease.
PRENATAL GENETIC COUNSELOR 2006 – 2010
Fetal and Women’s Center of Arizona – Phoenix, AZ.

Overview

Recessive disease carrier screening for 100+ genes is now being performed in the US and Europe. In comparison to minimal screening for thalassemia or cystic fibrosis, this method identifies more couples at risk of having children with genetic disease. It also presents challenges in genetic counseling and clinical implementation. We discuss experiences and considerations for this new protocol for population-based screening.